Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $41,264 | 9 | 70.2% |
| Honoraria | $7,215 | 2 | 12.3% |
| Unspecified | $5,540 | 3 | 9.4% |
| Travel and Lodging | $3,601 | 14 | 6.1% |
| Food and Beverage | $790.06 | 11 | 1.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $330.00 | 1 | 0.6% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $34,163 | 15 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $16,376 | 15 | $0 (2018) |
| CSL Behring | $8,201 | 10 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $1,400 | 1 | PFIZER INC. ($1,400) |
| 2020 | $13,066 | 4 | PFIZER INC. ($10,921) |
| 2019 | $8,877 | 12 | CSL Behring ($6,056) |
| 2018 | $19,255 | 12 | PFIZER INC. ($12,534) |
| 2017 | $16,143 | 11 | Novartis Pharmaceuticals Corporation ($9,655) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/06/2021 | PFIZER INC. | — | — | In-kind items and services | $1,400.00 | Research |
| Study: RIVIPANSEL CLINICAL PUBLICATION PROGRAM | ||||||
| 10/05/2020 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $6,781.25 | General |
| 09/25/2020 | PFIZER INC. | — | — | In-kind items and services | $940.00 | Research |
| Study: RIVIPANSEL CLINICAL PUBLICATION PROGRAM | ||||||
| 09/14/2020 | CSL Behring | — | Honoraria | Cash or cash equivalent | $2,145.00 | General |
| 09/01/2020 | PFIZER INC. | — | — | In-kind items and services | $3,200.00 | Research |
| Study: RIVIPANSEL CLINICAL PUBLICATION PROGRAM | ||||||
| 10/30/2019 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $330.00 | General |
| 08/05/2019 | CSL Behring | — | Honoraria | Cash or cash equivalent | $5,070.00 | General |
| 08/05/2019 | CSL Behring | — | Food and Beverage | In-kind items and services | $45.00 | General |
| 08/05/2019 | CSL Behring | — | Travel and Lodging | Cash or cash equivalent | $32.24 | General |
| 08/05/2019 | CSL Behring | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 08/05/2019 | CSL Behring | — | Food and Beverage | In-kind items and services | $10.00 | General |
| 08/05/2019 | CSL Behring | — | Food and Beverage | In-kind items and services | $10.00 | General |
| 08/04/2019 | CSL Behring | — | Travel and Lodging | In-kind items and services | $150.12 | General |
| 08/04/2019 | CSL Behring | — | Food and Beverage | In-kind items and services | $112.27 | General |
| 07/01/2019 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $740.00 | General |
| 06/11/2019 | CSL Behring | — | Travel and Lodging | In-kind items and services | $596.33 | General |
| 03/25/2019 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $1,750.70 | General |
| 10/08/2018 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $5,250.00 | General |
| 09/06/2018 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $6,375.00 | General |
| 05/19/2018 | Novartis Pharmaceuticals Corporation | CRIZANLIZUMAB (Biological) | Consulting Fee | Cash or cash equivalent | $5,680.00 | General |
| 05/19/2018 | Novartis Pharmaceuticals Corporation | CRIZANLIZUMAB (Biological) | Travel and Lodging | Cash or cash equivalent | $225.54 | General |
| 05/19/2018 | Novartis Pharmaceuticals Corporation | CRIZANLIZUMAB (Biological) | Travel and Lodging | In-kind items and services | $202.56 | General |
| 05/19/2018 | Novartis Pharmaceuticals Corporation | CRIZANLIZUMAB (Biological) | Food and Beverage | In-kind items and services | $107.14 | General |
| 05/18/2018 | Novartis Pharmaceuticals Corporation | CRIZANLIZUMAB (Biological) | Travel and Lodging | In-kind items and services | $381.00 | General |
| 05/18/2018 | Novartis Pharmaceuticals Corporation | CRIZANLIZUMAB (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RIVIPANSEL CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $5,540 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 50 | 51 | $8,925 | $1,706 |
| 2022 | 1 | 45 | 46 | $8,050 | $1,573 |
| 2021 | 1 | 46 | 46 | $8,050 | $1,690 |
| 2020 | 1 | 69 | 72 | $12,600 | $2,831 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 86077 | Blood bank physician services for cross match and/or evaluation and written report | Facility | 2023 | 50 | 51 | $8,925 | $1,706 | 19.1% |
| 86077 | Blood bank physician services for cross match and/or evaluation and written report | Facility | 2022 | 45 | 46 | $8,050 | $1,573 | 19.5% |
| 86077 | Blood bank physician services for cross match and/or evaluation and written report | Facility | 2021 | 46 | 46 | $8,050 | $1,690 | 21.0% |
| 86077 | Blood bank physician services for cross match and/or evaluation and written report | Facility | 2020 | 69 | 72 | $12,600 | $2,831 | 22.5% |
About Dr. Marilyn Telen, M.D
Dr. Marilyn Telen, M.D is a Hematology healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346399367.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marilyn Telen, M.D has received a total of $58,740 in payments from pharmaceutical and medical device companies, with $1,400 received in 2021. These payments were reported across 40 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($41,264).
As a Medicare-enrolled provider, Telen has provided services to 210 Medicare beneficiaries, totaling 215 services with total Medicare billing of $7,800. Data is available for 4 years (2020–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Hematology
- Other Specialties Anatomic Pathology & Clinical Pathology
- Location Durham, NC
- Active Since 01/09/2007
- Last Updated 09/11/2025
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1346399367
Products in Payments
- CRIZANLIZUMAB (Biological) $7,312
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Durham
Alan Carlson, M.d, M.D
Hematology — Payments: $2.0M
Lindsay Rein, M.d, M.D
Hematology — Payments: $49,361
Sascha Tuchman, Md, MD
Hematology — Payments: $37,535
Thomas Ortel, M.d, M.D
Hematology — Payments: $35,848
Gowthami Arepally, Md, MD
Hematology — Payments: $14,337
Dr. Niharika Mettu, Md, Phd, MD, PHD
Hematology — Payments: $6,332